Top product sales forecasts for 2018

The top-selling drugs of 2018 are set to be a mix of old-timers and newcomers, shows global consensus sales forecast data from EvaluatePharma. The top five products on this forecast list are repeat bestsellers, and AbbVie’s adalimumab held the top slot in both 2016 and 2017. Several of these top earners are likely to come under pressure in upcoming years from biosimilar launches…

Para acessar a publicação na íntegra clique aqui

Fonte: 86 | FEBRUARY 2018 | VOLUME 17